Trial: 202009003

A phase IB and randomized open-label phase II study of M6620 in combination with carboplatin/gemcitabine/avelumab in
patients with chemotherapy-naïve advanced non-small cell lung cancer of squamous cell histology

Phase

I/II

Principal Investigator

Morgensztern, Daniel

Disease Site

Lung

Learn more about this study at: clinicaltrials.gov